Rexam’s new child-resistant ophthalmic and nasal closure : continuing many decades of innovative child-resistant drug packaging
The U.S. Consumer Product Safety Commission (CPSC) requires child-resistant (CR) packaging for all products containing imidazolines (vasoconstrictor drugs). All prescription and OTC medications with 0.08 mg or more of imidazolines are impacted. The new regulation will be applicable in December 2013 and all manufacturers will have to switch to a child-resistant package by December 2014.
Rexam has developed a solution, discover features and benefits…